Sandoz announces further progress on its biosimilar pipeline, with release of positive results for denosumab integrated Phase I/III clinical trial - Press Release

ROSALIA study met primary endpoints, confirming proposed biosimilar denosumab matches reference product in terms of pharmacokinetics, pharmacodynamics

Related Keywords

United States ,Amgen Europe ,Florian Bieber ,Instagram ,International Osteoporosis Foundation ,Linkedin ,Global Head Of Development ,Twitter ,Drug Administration ,Novartis ,Exchange Commission ,Amgen Inc ,European Medicines Agency ,Facebook ,Global Head ,Biosimilar Denosumab ,